ANALYTICS PLATFORMS

 

 

Learn about new tools and platforms that are being developed to empower researchers.  

THIS YEAR’S WORLD LEADING ANALYTICS PLATFORMS SPEAKERS

 

 

 

Analytics Platforms, Tuesday 2 November 2021

08:40

Opening Remarks

Trevor Howe
09:00

Looking at the bigger picture: How do we make sure that we have the full picture with big data experiments

Joachim Reischl
09:20

Deep Medicine – towards the next generation of software-based precision medicine diagnostics

  • Evolution of precision medicine
  • AI in predicting clinical outcome
  • Software as Medical Device as Companion Diagnostic
Panel discussion
09:40

Essential Tools for Accelerating Pipeline Productivity & Success

What tools are in your toolkit? Join this leading biopharma panel discussion to find out how to give your AI-based drug discovery and development program a competitive edge and increase program success.
10:40

Networking Break

Stephan Schuster
Analytics Platforms
11:40

SARS Cov2 Environmental Surveillance

Analytics Platforms
12:00

Tiger Graph

Analytics Platforms
12:40

Databricks

Julia Maritz
Analytics Platforms
13:00

DOMI - Database of Microbial Host Interactions

13:20

Networking Lunch Break

Analytics Platforms
15:00

illumina

Nuray Yurt
Analytics Platforms
15:20

Global AI Implementation at Novartis

Analytics Platforms
15:40

Ramsey International Reserved

Avi Maayan
Analytics Platforms
16:00

Appyters: Turning Jupyter Notebooks into Data Driven Bioinformatics Web Apps

16:20

Networking Break

Panel discussion
Analytics Platforms
17:20

Dermatology and AI

18:00

Neri & Sons Band & Networking Drinks Reception

last published: 27/Jul/21 14:25

Analytics Platforms, Wednesday 3 November 2021

Steffen Roellinger
09:00

Decentralised Clinical Trials

  • Discussing the adoption of decentralised clinical trials at Bayer
  • New digital addoption
  • The Bayer trials transformaiton over COVID-19
Andrew Kasarskis
09:00

Digital transformation over COVID-19 – Challenges for the future and perpetuating the efforts

  • COVID-19 lead to digital innovation by necessity, including telehealth, new apps and digital technologies, and data fusion and sharing advances.
  • Large opportunities exist to do much better with learning from data, however.This requires the following operational and cultural change:
-Proactive collection and use of coherent data sets as a baseline for public health and the infrastructure development to support that work.-Recommitment to evidence-based medicine and timely, rigorous assessment of clinical utility through ongoing clinical research with well-powered studies of strong statistical design coupled to careful monitoring of large observational data.
Said Ismail
09:20

Qatar Genome; Big data from an underrepresented region

  • Overview of the Qatar Genome Project (QGP)
  • Contributions to Middle East Genomics
  • QGP role COVID-19 research
  • Strategy for precision medicine implementation
09:20

SevenBridges

Panel discussion
09:40

BC Platforms - Keynote Panel

Paul Agapow
09:40

How to be right: effective use of clinical models and machine learning in the clinic

    There is an increasing demand for a sophisticated model to predict patient outcomes and suggest treatmentsUnfortunately, most proposed clinical models are not fit for purpose, being biased, unvalidated, or irrelevantHere we suggest best practices for the development and deployment of complex ML algorithms, resulting in more successful and effective models
10:20

Networking Break + Speed Networking

Analytics Platforms
11:15

Chair's Remarks

Daniel Sabanés Bové
Analytics Platforms
11:20

NEST - web applications for clinical trial analyses

  • NEST is a platform with R-packages and R/Shiny framework started in Roche, where it is already used today in many clinical studies
  • Objective is to collaborate with other pharma companies and eventually regulators and open source.
  • Recently started development of biomarker analysis tools, including low dimensional (e.g. labs) and high dimensional (e.g. RNAseq) biomarkers.
Analytics Platforms
12:20

Sponsor

13:00

Networking Lunch Break

16:00

Networking Break

18:00

Drinks Reception

last published: 27/Jul/21 14:25

Analytics Platforms, Thursday 4 November 2021

Scott Chandler
09:00

Genetic Drivers of Response to Immunotherapy: Going Beyond the Tumor

09:20

GenomeSys

Thomas Hach
10:40

The Future of Precision Healthcare – Multi-Omics Humanized

  • Personalization of healthcare, not only of drug treatment, is the future
  • Patient influence, patient data and patient-desired outcomes are the most disruptive factors
  • How can we move from sterile biosignatures to a humanized approach?
last published: 27/Jul/21 14:25

GET INVOLVED AT BIODATA WORLD CONGRESS

 

 

TO SPONSOR


Alistair Wilmot
alistair.wilmot@terrapinn.com
0207 092 1174

 

 

TO SPEAK


Edward Glanville

edward.glanville@terrapinn.com
0207 092 1042

 

 

MARKETING OPPORTUNITIES


Onika Akhtar
onika.akhtar@terrapinn.com
0207 092 1034